BR9711117A - Oligossacarídios modificados. - Google Patents
Oligossacarídios modificados.Info
- Publication number
- BR9711117A BR9711117A BR9711117-1A BR9711117A BR9711117A BR 9711117 A BR9711117 A BR 9711117A BR 9711117 A BR9711117 A BR 9711117A BR 9711117 A BR9711117 A BR 9711117A
- Authority
- BR
- Brazil
- Prior art keywords
- modified oligosaccharides
- natural
- modified
- oligosaccharides
- oligosacaries
- Prior art date
Links
- 229920001542 oligosaccharide Polymers 0.000 title 1
- 150000002482 oligosaccharides Chemical class 0.000 title 1
- CERZMXAJYMMUDR-QBTAGHCHSA-N 5-amino-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid Chemical group N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO CERZMXAJYMMUDR-QBTAGHCHSA-N 0.000 abstract 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 abstract 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 abstract 1
- XBSNXOHQOTUENA-KRAHZTDDSA-N alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-L-Fuc-(1->4)]-D-GlcNAc Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O[C@]3(O[C@H]([C@H](NC(C)=O)[C@@H](O)C3)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](NC(C)=O)C(O)O[C@@H]1CO XBSNXOHQOTUENA-KRAHZTDDSA-N 0.000 abstract 1
- NIGUVXFURDGQKZ-UQTBNESHSA-N alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc Chemical class O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O[C@]3(O[C@H]([C@H](NC(C)=O)[C@@H](O)C3)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O NIGUVXFURDGQKZ-UQTBNESHSA-N 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- 229950006780 n-acetylglucosamine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Patente de Invenção:<B>"OLIGOSSACARìDIOS MODIFICADOS"<D>. Derivados de sialil-Lewis X e A, em que o resíduo de ácido neuramínico natural e o monómero de N-acetilglucosamina natural são substituídos.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96810526 | 1996-08-08 | ||
| EP96810527 | 1996-08-08 | ||
| EP96810636 | 1996-09-26 | ||
| PCT/EP1997/004279 WO1998006730A1 (en) | 1996-08-08 | 1997-08-06 | Modified oligosaccharides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9711117A true BR9711117A (pt) | 1999-09-08 |
Family
ID=27237868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9711117-1A BR9711117A (pt) | 1996-08-08 | 1997-08-06 | Oligossacarídios modificados. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0920437A1 (pt) |
| JP (1) | JP2000516224A (pt) |
| KR (1) | KR20000029862A (pt) |
| CN (1) | CN1227563A (pt) |
| AR (1) | AR008283A1 (pt) |
| AU (1) | AU720381B2 (pt) |
| BR (1) | BR9711117A (pt) |
| CA (1) | CA2260854A1 (pt) |
| CO (1) | CO4900075A1 (pt) |
| CZ (1) | CZ39099A3 (pt) |
| ID (1) | ID18010A (pt) |
| IL (1) | IL127908A0 (pt) |
| NO (1) | NO990497L (pt) |
| NZ (1) | NZ334048A (pt) |
| PE (1) | PE99298A1 (pt) |
| PL (1) | PL331286A1 (pt) |
| SK (1) | SK15699A3 (pt) |
| TR (1) | TR199900245T2 (pt) |
| WO (1) | WO1998006730A1 (pt) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5888984A (en) * | 1994-05-12 | 1999-03-30 | Dermal Research Laboratories, Inc. | Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
| AU2745700A (en) | 1999-02-01 | 2000-08-18 | Dermal Research Laboratories, Inc. | A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
| US7879824B2 (en) | 2001-07-31 | 2011-02-01 | Dermal Research Laboratories, Inc. | Methods of preventing or treating diseases and conditions using complex carbohydrates |
| EP1539251A4 (en) * | 2002-07-03 | 2009-02-25 | Glycomimetics Inc | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND THERAPY OF MEDICAL DISEASES WITH ANGIOGENESIS |
| MXPA05003844A (es) | 2002-10-11 | 2005-06-22 | Yamanouchi Europ Bv | Compuestos con base de glucosa con afinidad para p-selectina. |
| DE602004011272T2 (de) | 2003-11-19 | 2008-12-24 | Glycomimetics, Inc. | Spezifischer antagonist sowohl für e- als auch p-selektine |
| EP1685145A2 (en) * | 2003-11-19 | 2006-08-02 | GlycoMimetics, Inc. | Glycomimetic antagonists for both e- and p-selectins |
| WO2006127906A1 (en) * | 2005-05-25 | 2006-11-30 | Glycomimetics, Inc. | Heterobifunctional compounds for selectin inhibition |
| EP1928892B1 (en) | 2005-08-09 | 2011-10-12 | GlycoMimetics, Inc. | Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas |
| ES2651929T3 (es) | 2005-09-02 | 2018-01-30 | Glycomimetics, Inc. | Inhibidores de pan-selectina heterobifuncionales |
| EP2457573A1 (en) * | 2007-02-09 | 2012-05-30 | GlycoMimetics, Inc. | Methods of use of glycomimetics with replacements for hexoses and N-Acetyl hexosamines |
| US9486497B2 (en) | 2007-12-10 | 2016-11-08 | The University Of Queensland | Treatment of immunocompromised conditions |
| US8895510B2 (en) | 2008-04-08 | 2014-11-25 | Glycomimetics, Inc. | Pan-selectin inhibitor with enhanced pharmacokinetic activity |
| US8921328B2 (en) | 2010-09-14 | 2014-12-30 | Glycomimetics, Inc. | E-selectin antagonists |
| PL2794626T6 (pl) | 2011-12-22 | 2020-11-02 | Glycomimetics, Inc. | Związki antagonistyczne E-selektyny |
| US9867841B2 (en) | 2012-12-07 | 2018-01-16 | Glycomimetics, Inc. | Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells |
| EP3569609A1 (en) | 2014-12-03 | 2019-11-20 | GlycoMimetics, Inc. | Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors |
| EP3405473A1 (en) | 2016-01-22 | 2018-11-28 | GlycoMimetics, Inc. | Glycomimetic inhibitors of pa-il and pa-iil lectins |
| WO2017151708A1 (en) | 2016-03-02 | 2017-09-08 | Glycomimetics, Inc. | Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin |
| EP3497131B1 (en) | 2016-08-08 | 2022-03-09 | GlycoMimetics, Inc. | Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4. |
| EP3522931A1 (en) | 2016-10-07 | 2019-08-14 | GlycoMimetics, Inc. | Highly potent multimeric e-selectin antagonists |
| WO2018169853A1 (en) | 2017-03-15 | 2018-09-20 | Glycomimetics, Inc. | Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists |
| WO2019108750A1 (en) | 2017-11-30 | 2019-06-06 | Glycomimetics, Inc. | Methods of mobilizing marrow infiltrating lymphocytes and uses thereof |
| CA3085356A1 (en) | 2017-12-29 | 2019-07-04 | Glycomimetics, Inc. | Heterobifunctional inhibitors of e-selectin and galectin-3 |
| CN108299525B (zh) * | 2018-01-05 | 2021-03-26 | 佛山科学技术学院 | 路易斯寡糖-x的合成方法 |
| AU2019230013A1 (en) | 2018-03-05 | 2020-09-10 | Glycomimetics, Inc. | Methods for treating acute myeloid leukemia and related conditions |
| US11845771B2 (en) | 2018-12-27 | 2023-12-19 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
| CN109762032A (zh) * | 2019-01-16 | 2019-05-17 | 天津科技大学 | 一种磺酸化路易斯x三糖及其合成方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993023031A1 (en) * | 1992-05-08 | 1993-11-25 | The Biomembrane Institute | Multivalent mimetics and peptide mimetics for blocking carbohydrate-dependent cellular interaction and for eliciting anticarbohydrate t-cell response |
| CA2157489A1 (en) * | 1993-03-04 | 1994-09-15 | Masaaki Numata | Lewis-associated compound, process for producing the same, and anti-inflammatory |
| JPH08510729A (ja) * | 1993-05-14 | 1996-11-12 | サイテル コーポレイション | 細胞接着のインヒビターとしてのシアリルＬｅ▲上ｘ▼類似体 |
| CN1176644A (zh) * | 1994-12-28 | 1998-03-18 | 住友制药株式会社 | 路易斯x衍生物及其制备方法 |
-
1997
- 1997-08-06 KR KR1019997001025A patent/KR20000029862A/ko not_active Withdrawn
- 1997-08-06 CN CN97197077A patent/CN1227563A/zh active Pending
- 1997-08-06 CA CA002260854A patent/CA2260854A1/en not_active Abandoned
- 1997-08-06 TR TR1999/00245T patent/TR199900245T2/xx unknown
- 1997-08-06 PL PL97331286A patent/PL331286A1/xx unknown
- 1997-08-06 EP EP97941916A patent/EP0920437A1/en not_active Withdrawn
- 1997-08-06 NZ NZ334048A patent/NZ334048A/xx unknown
- 1997-08-06 SK SK156-99A patent/SK15699A3/sk unknown
- 1997-08-06 WO PCT/EP1997/004279 patent/WO1998006730A1/en not_active Ceased
- 1997-08-06 IL IL12790897A patent/IL127908A0/xx unknown
- 1997-08-06 BR BR9711117-1A patent/BR9711117A/pt not_active Application Discontinuation
- 1997-08-06 AR ARP970103580A patent/AR008283A1/es unknown
- 1997-08-06 AU AU43788/97A patent/AU720381B2/en not_active Ceased
- 1997-08-06 JP JP10509358A patent/JP2000516224A/ja active Pending
- 1997-08-06 CZ CZ99390A patent/CZ39099A3/cs unknown
- 1997-08-07 PE PE1997000688A patent/PE99298A1/es not_active Application Discontinuation
- 1997-08-08 CO CO97045596A patent/CO4900075A1/es unknown
- 1997-08-08 ID IDP972766A patent/ID18010A/id unknown
-
1999
- 1999-02-03 NO NO990497A patent/NO990497L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998006730A1 (en) | 1998-02-19 |
| JP2000516224A (ja) | 2000-12-05 |
| NO990497D0 (no) | 1999-02-03 |
| ID18010A (id) | 1998-02-19 |
| IL127908A0 (en) | 1999-11-30 |
| CZ39099A3 (cs) | 1999-05-12 |
| NZ334048A (en) | 2000-05-26 |
| CA2260854A1 (en) | 1998-02-19 |
| CN1227563A (zh) | 1999-09-01 |
| TR199900245T2 (xx) | 1999-05-21 |
| PE99298A1 (es) | 1999-01-21 |
| PL331286A1 (en) | 1999-07-05 |
| AR008283A1 (es) | 1999-12-29 |
| CO4900075A1 (es) | 2000-03-27 |
| AU720381B2 (en) | 2000-06-01 |
| NO990497L (no) | 1999-03-24 |
| KR20000029862A (ko) | 2000-05-25 |
| EP0920437A1 (en) | 1999-06-09 |
| AU4378897A (en) | 1998-03-06 |
| SK15699A3 (en) | 1999-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9711117A (pt) | Oligossacarídios modificados. | |
| BR9813154A (pt) | Compósitos de fibra celulósica | |
| ES2182906T3 (es) | Grapa quirurgica helicoidal. | |
| FR2704135B1 (fr) | Agrafe d'osteosynthese. | |
| AUPN261895A0 (en) | Preparation and use of sulfated oligosaccharides | |
| BR9909242A (pt) | Inibidores de fosfolipase a2 | |
| BR0010220A (pt) | Compostos de pirimidinona | |
| FI953817L (fi) | Koostumukset ja menetelmät vetyperoksidin tuhoamiseksi | |
| FR2709679B1 (fr) | Compositions aqueuses concentrées d'alkylpolyglycosides et leurs utilisations. | |
| BR9801507A (pt) | Despolimerização de poliamidas. | |
| DE69412164D1 (de) | Nachrichtenübertragungssystem | |
| BR9605855A (pt) | Composição detergente e macromolécula dendrítica | |
| TR200001102T2 (tr) | İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları. | |
| DE69625230D1 (de) | Thrombininhibitoren | |
| ES2172682T3 (es) | Preparaciones desodorantes con contenido en quitosano, clorohidrato de aluminio e inhibidores de esterasa. | |
| EP0649879A3 (en) | Siloxane compositions having high tear resistance. | |
| FR2709598B1 (fr) | Construction de magnétron utilisable en particulier en tant que magnétron relativiste. | |
| DE69840673D1 (de) | Modifizierte polysaccharide mit veränderter biologischer erkennung | |
| AU6849198A (en) | Neurotrypsin | |
| IL106237A0 (en) | Piperidyl amides,sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis | |
| BR9801143A (pt) | Copolìmeros de bloco de siloxano inovativos com espaçamento rìgidos e uso dos mesmos. | |
| FI943069L (fi) | Kloorittomia, mahdollisesti vetypitoisia fluorihiilivetyjä sisältävät koostumukset | |
| IT1277329B1 (it) | Procedimento per la metilazione del 2,2,6,6-tetrametil-4-piperidone (triacetonammina) | |
| FR2701520B1 (fr) | Dispositif de fixation notamment de tablettes, d'étagères ou autres. | |
| BR9813897A (pt) | Derivados de bifenila como farmacêuticos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |